Does TAGRAXOFUSP-ERZS Cause Disease progression? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Disease progression have been filed in association with TAGRAXOFUSP-ERZS. This represents 7.5% of all adverse event reports for TAGRAXOFUSP-ERZS.
33
Reports of Disease progression with TAGRAXOFUSP-ERZS
7.5%
of all TAGRAXOFUSP-ERZS reports
16
Deaths
6
Hospitalizations
How Dangerous Is Disease progression From TAGRAXOFUSP-ERZS?
Of the 33 reports, 16 (48.5%) resulted in death, 6 (18.2%) required hospitalization, and 2 (6.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAGRAXOFUSP-ERZS. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does TAGRAXOFUSP-ERZS Cause?
Capillary leak syndrome (110)
Pyrexia (45)
Death (36)
Thrombocytopenia (26)
Blood albumin decreased (24)
Acute kidney injury (23)
Off label use (23)
Weight increased (22)
Transaminases increased (21)
Tumour lysis syndrome (21)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TAGRAXOFUSP-ERZS Alternatives Have Lower Disease progression Risk?
TAGRAXOFUSP-ERZS vs TAHOR
TAGRAXOFUSP-ERZS vs TALAZOPARIB
TAGRAXOFUSP-ERZS vs TALC
TAGRAXOFUSP-ERZS vs TALIGLUCERASE ALFA
TAGRAXOFUSP-ERZS vs TALIMOGENE LAHERPAREPVEC